EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study

Sean W X Ong iD, Jin Luo, Daniel J Fridman, Samantha M Lee, Jennie Johnstone, Kevin L Schwartz, Christina Diong, Samir N Patel, Derek R Macfadden, Bradley J Langford iD, Steven Y C Tong iD, Kevin A Brown iD und 1 weitere

Journal of Antimicrobial Chemotherapy · 01.08.2024 · 79 (8) · 2053-2061

DOI: 10.1093/jac/dkae211 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 03.07.2024. Verfasst von Sean W X Ong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Bacteremia, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, ICES, Ontario Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The risk factors and outcomes associated with persistent bacteraemia in Gram-negative bloodstream infection (GN-BSI) are not well described. We conducted a follow-on analysis of a retrospective population-wide cohort to characterize persistent bacteraemia in patients with GN-BSI.

Methods

We included all hospitalized patients >18 years old with GN-BSI between April 2017 and December 2021 in Ontario who received follow-up blood culture (FUBC) 2–5 days after the index positive blood culture. Persistent bacteraemia was defined as having a positive FUBC with the same Gram-negative organism as the index blood culture. We identified variables independently associated with persistent bacteraemia in a multivariable logistic regression model. We evaluated whether persistent bacteraemia was associated with increased odds of 30- and 90-day all-cause mortality using multivariable logistic regression models adjusted for potential confounders.

Results

In this study, 8807 patients were included; 600 (6.8%) had persistent bacteraemia. Having a permanent catheter, antimicrobial resistance, nosocomial infection, ICU admission, respiratory or skin and soft tissue source of infection, and infection by a non-fermenter or non-Enterobacterales/anaerobic organism were associated with increased odds of having persistent bacteraemia. The 30-day mortality was 17.2% versus 9.6% in those with and without persistent bacteraemia (aOR 1.65, 95% CI 1.29–2.11), while 90-day mortality was 25.5% versus 16.9%, respectively (aOR 1.53, 95% CI 1.24–1.89). Prevalence and odds of developing persistent bacteraemia varied widely depending on causative organism.

Conclusions

Persistent bacteraemia is uncommon in GN-BSI but is associated with poorer outcomes. A validated risk stratification tool may be useful to identify patients with persistent bacteraemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaGram-Negative Bacterial InfectionsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedOntarioRisk FactorsGram-Negative BacteriaAdultBlood CultureCross InfectionAged, 80 and overAnti-Bacterial AgentsClinical Relevance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
  • Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
  • Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • ICES, Toronto, Canada.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Division of Infectious Diseases, Sinai Health, Toronto, Canada.

ORCID-Profile: Sean W X Ong, Bradley J Langford, Steven Y C Tong, Kevin A Brown

Förderung

  • CIHR
  • ICES
  • Ontario Ministry of Health
  • Ministry of Long-Term Care

Zitieren

APA

Ong, S. W. X., Luo, J., Fridman, D. J., Lee, S. M., Johnstone, J., Schwartz, K. L., Diong, C., Patel, S. N., Macfadden, D. R., Langford, B. J., Tong, S. Y. C., Brown, K. A., & Daneman, N. (2024). Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study. Journal of Antimicrobial Chemotherapy, 79(8), 2053-2061. https://doi.org/10.1093/jac/dkae211

Vancouver

Ong SWX, Luo J, Fridman DJ, Lee SM, Johnstone J, Schwartz KL, et al. Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2024;79(8):2053-2061. doi:10.1093/jac/dkae211

BibTeX
@article{Ong2024,
  author = {Ong, Sean W X and Luo, Jin and Fridman, Daniel J and Lee, Samantha M and Johnstone, Jennie and Schwartz, Kevin L and Diong, Christina and Patel, Samir N and Macfadden, Derek R and Langford, Bradley J and Tong, Steven Y C and Brown, Kevin A and Daneman, Nick},
  title = {Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {8},
  pages = {2053--2061},
  doi = {10.1093/jac/dkae211}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche